网站大量收购闲置独家精品文档,联系QQ:2885784924

乳腺癌干细胞突变与腋窝淋巴结转移的相关性探索.ppt

乳腺癌干细胞突变与腋窝淋巴结转移的相关性探索.ppt

  1. 1、本文档共11页,可阅读全部内容。
  2. 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
  3. 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  4. 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
Correlation of Breast Cancer Axillary Lymph Node Metastases With Stem Cell Mutations 乳腺癌干细胞突变与腋窝淋巴结转移的相关性 Background In stem cell theory, breast cancer stem and progenitor cells (BCSCs) are central to cancer proliferation, metastaticpotential,andoutcomemeasures. Breast cancer stemandprogenitor cells have the capacity to initiate tumors, produce multipletumorcell lineages,andmaintain a continuous population of malignant stem cells through self-renewal. Previous research found no oncologic abnormalities in stem and progenitor cells in benign breast tissue; however, oncogenes in thePI3K/Akt signalingpathwaywere identified instemand progenitor cell populations in breast cancer. 乳腺癌干细胞和祖细胞 (BCSCs) 是癌症增殖、转移潜能及转归结局的中心因素。乳腺癌干细胞和祖细胞可分化产生多种肿瘤细胞系,并通过自我更新而维持恶性干细胞群的延续。 在乳腺癌干细胞和祖细胞群中发现 PI3K/Akt 通路涉及到细胞增殖、信号传导、转移潜能等功能,也是目前乳腺癌临床试验青睐的化疗靶点。 Purpose Mutations in oncogenes AKT1, HRAS, and PIK3CA in breast cancers result in abnormal PI3K/Akt signaling and tumor proliferation. They occur in ductal carcinoma in situ,in breast cancers, and in breast cancer stem and progenitor cells (BCSCs). To determine if variability in clinical presentation at diagnosis correlates withPI3K/Akt mutations in BCSCs and provides an early prognostic indicator of increasedprogression and metastatic potential. 在乳腺癌中,癌基因 AKT1、HRAS、PIK3CA 的突变会导致PI3K/Akt 信号通路传导异常和肿瘤异常增殖。这种现象常见于浸润性导管癌以及乳腺癌干细胞及祖细胞 (BCSCs)中。 本实验主要研究乳腺癌干细胞(BCSCs)中 PI3K/Akt 信号通路的突变与乳腺癌的不同临床表现之间的相关性,为判断疾病加速进展和潜在转移提供早期的预后指标。 Methods Womenwithinvasiveduc-tal carcinoma of the breast exceeding 1.0 cm were identified at tumor board meetings and enrolled in the study. Solid-tissuebreastspecimenswerecollectedatthetimeofmastec-tomy or lumpectomy before any adjuvant treatment. Specimens were obtained directly from the operating room andevaluated by a pathologist, and approximately1gof tumor tissuewas immediately transferred to the laboratory for processinginmammaryepithelial cell–specificmedium 研究对象为30例浸润性导管癌的患者(IA 至 IIIB 期),肿瘤直径1cm,术前未行任何辅助治疗。 用流式细胞仪

文档评论(0)

贪玩蓝月 + 关注
实名认证
内容提供者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档